Investerms
  • Home
  • Top News
  • Investor's Edge
  • The Elite Trader
  • Smart Money
  • Real Estate Guide
  • Practical Retirement
| Advanced search
Market Snapshot
Dow:
Nasdaq:
S&P 500:
8280.74 (-223.32)
1796.52 (-49.20)
896.42 (-26.91)

Featured Articles
Recover from Losses
Learn how to use a simply stock options strategy to cut your breakeven in half and quickly recoup losses!

How to Recession-Proof
Learn where to invest your money to minimize damage from the impending U.S. recession.

Gauge Stock Momentum
Learn how to determine when your investments have begun to lose steam to sell out before the crowd!

Research Tools
SEC Filings Analysis
Executive Compensation

Home | Top News | BioSolar Surges - But Funding A Question Mark

BioSolar Surges - But Funding A Question Mark

16 June, 2008 03:45:00 Thom Buschman
Font size: Decrease font Enlarge font
Penny-stock BioSolar, Inc. (OTC: BSRC) is up more than 25% in morning trading Monday on volume of more than 380,000 shares on the announcement of a manufacturing partner for its technology.

The Santa Clarita, California-based developer of new solar cell technology announced that Connecticut-based Rowland Technologies, Inc. has been selected to manufacture BioSolar’s BioBacksheet solar cell component.

BioBacksheet is the result of BioSolar’s efforts to reduce solar electricity component costs while make solar energy more environmentally friendly. Despite solar energy being renewable and pollution-free, petroleum is still a major component of solar cells. In a GreenTechMedia.com news article on BioSolar, CEO David Lee says BioBacksheet is not only produced from plant-based materials, but these plants are not a food source.

Though BioBacksheet has yet to be tested independently, an especially important step because solar panels are generally expected to last at least 20 years, if viable a large market waits as the solar sector is currently hamstringed by component shortages.

Also, though BioSolar has selected a manufacturing partner, the company still has to raise the money to actually fund manufacturing – founded in 2006, the BioSolar only netted $3 million in its IPO. CEO Lee admitted that more capital is needed for manufacturing, but just how or when it will be raised, and how much current equity will be diluted in the process, is not known.

As of publication, BioSolar, Inc. shares are up 26.92% to $0.50.
Add to: Add to your del.icio.us del.icio.us | Digg this story Digg
  • email Email to a friend
  • print Print version
  • Plain text Plain text
Tags
No tags for this article
Rate this article
0

Related news
  • How Much Do You Really Need?
  • 5 Easy Steps to Create a Budget
  • A Look at Commercial Deal Financing
  • Candlestick Charts 101
  • Recession-Proof Your Portfolio
  • Top News
  • Investor's Edge
  • The Elite Trader
  • Smart Money
  • Real Estate Guide
  • Practical Retirement
cron Home | Set as homepage | Add to favorites | Rss / Atom | Plain text | Archive

Copyright © 2009 Accelerize New Media Inc. (OTC: ACLZ). All Rights Reserved. Privacy Policy | Dislcaimer | Contact Us
12121 Wilshire Blvd., Suite 322, Los Angeles, CA 90025 1-800-810-8815
 
Close Window

Name: E-Mail:


I agree to Terms and Conditions